Skip to main content
. 2016 Aug;8(8):1995–2003. doi: 10.21037/jtd.2016.06.39

Table 1. Results of pulmonary function tests, blood gas analysis, and 6MWT.

Parameters All subjects (n=130) Stage I (n=11) Stage II (n=69) Stage III (n=11) Stage IV (n=39) Adjusted P
Pulmonary function tests
   FEV1 (% pred) 80 [31] 97 [19] 83 [25] 90 [11] 66 [30]a,b,c 0.00001
   FVC (% pred) 92 [24] 98 [26] 96 [21] 102 [19] 79 [32]a,b,c 0.001
   TLC (% pred) 90 [19] 88 [14] 90 [21] 93 [29] 88 [24] 0.644
   FEV1/FVC (%) 75 [15] 80 [8] 75 [15] 79 [12] 71 [24]a,b,c 0.011
   DLco (% pred) 71 [25] 82 [18] 76 [23] 73 [17] 55 [23]a,b,c 0.00001
   Kco (% pred) 91 [25] 94 [21] 94 [22] 86 [12] 77 [34]a,b 0.0004
Blood gases
   Resting PaO2 (mmHg) 90 [12] 89 [9] 90 [14] 91 [3] 88 [13] 0.644
   Resting AaDO2 (mmHg) 16 [12] 11 [13] 16 [8] 14 [8] 23 [12] 0.15
   VO2 peak (mL/kg/min) 20.2 [9] 23 [9] 21.3 [8] 21.3 [11] 16.9 [6]a,b 0.021
   VO2 peak (% pred) 69 [9] 74 [31] 74 [28] 70 [36] 59 [26]a,b,c 0.042
   Peak PaO2 (mmHg) 84 [25] 97 [17] 87 [21] 94 [12] 69 [22]a,b,c 0.011
   Peak AaDO2 (mmHg) 29 [19] 15 [23] 27 [13] 24 [15] 44 [23]a,b,c 0.011
6MWT
   Distance (m) 450 [100] 460 [110] 450 [100] 490 [100] 460 [125] 0.644
   Resting SpO2 (%) 96 [1] 96 [2] 97 [1] 96 [1] 96 [3] 0.644
   Nadir SpO2 (%) 94 [6] 95 [4] 94 [3] 96 [3] 89 [12]a,b,c 3×10–8
   ∆SpO2-6MWT (%) 2 [4] 2 [2] 2 [3] 0 [2]d 4 [9]b,c 0.011

Data are presented as the median and [interquartile range]. a, P<0.05 between stages I and IV; b, P<0.05 between stages II and IV; c, P<0.05 between stages III and IV; d, P<0.05 between stages II and III. 6MWT, 6-minute walk test; ∆SpO2, oxygen desaturation [(resting – nadir) SpO2]; AaDO2, alveolar-to-arterial oxygen pressure difference; DLco, diffusing capacity of the lung for carbon monoxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; Kco, carbon monoxide transfer coefficient; PaO2, partial pressure of oxygen; pred, predicted; TLC, total lung capacity; VO2 peak, peak oxygen uptake.